Jubilant Biosys Limited#96, Industrial Suburb 2nd Stage,
Yeshwantpur, Bengaluru – 560 022,Karnataka, India

PRESS RELEASE
Bengaluru, 28 November, 2019JUBILANT BIOSYS COMMENCES MAJOR CAPACITY EXPANSIONSFOR ITS DRUG DISCOVERY SERVICES BUSINESS
Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Lifesciences Limited, today
announced commencement of two expansion projects in Greater Noida and Bengaluru.
Due to growing customer demand for its range of functional and integrated drug discovery
services, Jubilant Biosys has started design and construction of brand new and state-of-theart chemistry services laboratories on the existing Jubilant Greater Noida site. The chemistry
FTE capacity will be doubled and operations are expected to commence from H2 2020. The
new site can accommodate up to 500 Chemistry FTE’s. The site will be designed for thehighest global compliance standards and deliver superior speed and quality in the entire drug
discovery process.
In Bengaluru, Jubilant Biosys has obtained a 10-acre plot in the Devanahalli Industrial Park
which is adjacent to the International Airport. A completely new drug discovery services site
will be constructed in phases for further expansions.
In addition, we have formed a new digital business unit comprising of Bio-Informatics, Datacuration for AI/ML, TrialStat EDC software as well as discovery focussed AI/ML capabilities.
This business unit will also further expand on the new site and deliver increased benefits toour customers.
Marcel Velterop, President – Jubilant Biosys and CDMO, said: “The improving customer
confidence earned through exemplary scientific execution and a positive outlook in the global
drug discovery industry has resulted in the largest investment program in Jubilant Biosys since
its inception. We will soon be able to offer our customers much improved capacity andservices as well as ability to deliver an integrated IND package along with superior functional
discovery services. A combination of the best talent and state-of-the-art technology andinstrumentation will be offered to pursue drug discovery collaborations and help deliver new
innovation to patients faster than ever. ”
About Jubilant Biosys Limited:
Jubilant Biosys, a subsidiary of Jubilant Life sciences Ltd, an integrated global pharmaceuticaland life sciences company, has presence in Bengaluru and Noida in India. Jubilant Biosys offers
contract research & development services for global pharmaceutical innovators. Biosys has
demonstrated expertise in functional services such as Biology, DMPK, Toxicology as well as
Medicinal Chemistry and PR&D and GMP scale-up capabilities up to phase II. It has integrated1

discovery expertise with a track record of over 75 programs in multiple therapeutic areas
including but not limited to Oncology, Metabolic Disorders, Pain & Inflammation, CNS andexpanding into Rare Diseases. In addition, it markets “TrialStattm”, a proprietary and flexible
clinical trial data capture software and has started AI/ML activities in drug discovery under its
Digital initiative. For more info: www.jubilantbiosys.com.
About Jubilant Life Sciences Limited:
Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciencescompany engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery &Development Solutions businesses. The Pharmaceutical segment is engaged in manufacturing
and supply of Radiopharmaceuticals with a network of over 50 radio-pharmacies in the US,
Allergy Therapy Products, Contract Manufacturing of Sterile Injectables & Non-sterileproducts, APIs and Solid Dosage Formulations through six USFDA approved manufacturing
facilities in the US, Canada and India. The Life Science Ingredients segment, is engaged inSpecialty Intermediates, Nutritional Products and Life Science Chemicals through five
manufacturing facilities in India. Drug Discovery & Development Solutions comprises Drug
Discovery Services (DDS) business through Jubilant Biosys Limited & Jubilant Chemsys Limitedand Proprietary Drug Discovery business through Jubilant Therapeutics. DDS provides
innovation and collaborative research through two world class research centers in India andProprietary Drug Discovery is an innovative biopharmaceutical company developing
breakthrough therapies in the area of oncology and auto-immune disorders. Jubilant LifeSciences Limited has a team of around 7,700 multicultural people across the globe and iscommitted to deliver value to its customers across over 100 countries. The Company is wellrecognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies
globally. For more info: www.jubl.com.
For more information, please contact:
Drishti Asthana
Jubilant Biosys Limited
Ph: +91-9899033635
E-mail: drishti.asthana@jubilantbiosys.com

2